3 Humongous Health-Care Stocks This Week: Dendreon Corporation (DNDN), Neurocrine Biosciences, Inc. (NBIX)

Page 2 of 2

Lagniappe
The Super Bowl is over, but in honor of the New Orleans tradition of lagniappe, this week’s humongous list of health-care news offered a little something extra from humongous health-care stock Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY).

Oncolytics shares jumped 12% this week, and nearly 22% on Friday, after the company announced positive results from a phase 2 study of cancer drug Reolysin. Of the patients with squamous cell carcinoma of the lung, 95% experienced shrinkage of their tumors. The average tumor-size reduction for all patients in the study was 33.7%.

It should be noted that there were only 20 patients in this study, and good results from early and mid-stage studies with small sample sizes don’t always translate to similar results from larger studies. But good news is still good news. As they say in New Orleans, Laissez les bons temps rouler. Let the good times roll.

The article 3 Humongous Health-Care Stocks This Week originally appeared on Fool.com and is written by Keith Speights.

Fool contributor Keith Speights has no position in any stocks mentioned. The Motley Fool owns shares of Dendreon and has options on Herbalife.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Page 2 of 2